July 21, 2018

Most announcements of new therapies for diabetes are made by branded drug companies and clinicians, and patients have learned about the “sticker shock” that is associated with these new medications. This week we have a feature that bucks the system, as new research on an old blood pressure medication shows a lot of promise for insulin using patients.

*****************************

We can make a difference!

*****************************

Dave Joffe

Editor-in-chief